Astellas Pharma Inc. - Begin Period Cashflow

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Begin-Period-Cashflow" stands at 0.9642 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 03/31/2014.

Astellas Pharma Inc.'s first quarter result of 0.1884 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 4.73 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of 0.1884 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -43.88 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of 0.9642 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -13.25 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -35.08 percent compared to the value the year prior.
The 1 year change in percent is -35.08.
The 3 year change in percent is -25.05.
The 5 year change in percent is -17.37.
The 10 year change in percent is -40.81.

The Serie's long term average value is 1.21 Trillion Japanese Yens. It's latest available value, on 06/30/2025, is 20.53 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2012, to it's latest available value, on 06/30/2025, is +449.49%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is -42.65%.